
PMC:7358770 / 36711-36858
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T394 | 23-24 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T550 | 70-78 | Chemical | denotes | antigens | http://purl.obolibrary.org/obo/CHEBI_59132 |
T551 | 94-107 | Chemical | denotes | nanoparticles | http://purl.obolibrary.org/obo/CHEBI_50803 |
T552 | 129-140 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32679328-27552321-48281356 | 142-145 | 27552321 | denotes | 133 |
T19466 | 142-145 | 27552321 | denotes | 133 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T226 | 0-147 | Sentence | denotes | The study demonstrates a simple and reliable method in bridging viral antigens with synthetic nanoparticles for improved vaccine application [133]. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1023 | 55-63 | GO:0030674 | denotes | bridging |
T1024 | 64-69 | NCBITaxon:10239 | denotes | viral |
T1025 | 70-78 | CHEBI:59132;CHEBI:59132 | denotes | antigens |
T40309 | 3-8 | NCBITaxon:10239 | denotes | stud |